iBio, Inc. (IBIO) Financials
IBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 85.8 million | 8.3 million |
| Dec. 31, 2025 | 64.4 million | 7.8 million |
| Sept. 30, 2025 | 64.2 million | 8.1 million |
| June 30, 2025 | 23.2 million | 8.3 million |
IBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -6.1 million | 377000 |
| Dec. 31, 2025 | -5.8 million | 253000 |
| Sept. 30, 2025 | -5.7 million | 323000 |
| June 30, 2025 | -4.6 million | 270000 |
IBIO Net Income
No data available :(
IBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 74.8 million | - | 1.8 million |
| Dec. 31, 2025 | 52.7 million | - | 2.5 million |
| Sept. 30, 2025 | 49.6 million | - | 2.6 million |
| June 30, 2025 | 8.6 million | - | 2.7 million |
IBIO Shares Outstanding
IBIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 11000 | 3.3 million | 5.1 million | - |
| Dec. 31, 2025 | 516000 | 4.3 million | 5.2 million | - |
| Sept. 30, 2025 | 32000 | 3.6 million | 2.5 million | - |
| June 30, 2025 | 1000 | 3.2 million | 2.2 million | - |
IBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 250000 |
| Dec. 31, 2025 | - | 241000 |
| Sept. 30, 2025 | 100000 | 289000 |
| June 30, 2025 | 200000 | - |
IBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
IBIO
Price: $1.39
52 week price:
Earnings Per Share: -0.56 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 26.5 million